AFINITOR-5mg (Everolimus Tablet) 5mg

AFINITOR 5mg tablets contain everolimus, an mTOR inhibitor used for certain types of cancer and tuberous sclerosis complex. This prescription medicine is supplied in a 30-tablet pack. Always follow your healthcare provider’s instructions when using AFINITOR 5mg.

Strength

5mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Novartis Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Everolimus, the active ingredient in AFINITOR 5mg tablets, is used to treat advanced kidney cancer, pancreatic neuroendocrine tumors, and breast cancer in postmenopausal women. It is also prescribed for adults and children with tuberous sclerosis complex to manage seizures and non-cancerous kidney tumors. AFINITOR 5mg may be used when other treatments have not been effective.

Side Effects

AFINITOR 5mg tablets work by blocking a protein that helps cancer cells grow. This may slow or stop the growth of tumors in certain conditions. Some people notice changes in appetite or mild fatigue while taking this medication. These effects vary from person to person and should be discussed with a healthcare professional.

Precautions & Warnings

Store AFINITOR 5mg tablets at room temperature away from moisture and heat. Keep the bottle tightly closed and out of reach of children. Do not use if the seal is broken or the tablets show signs of damage. Always check the expiration date before taking. Report any unusual symptoms to your doctor promptly.

Avoid Interactions

AFINITOR 5mg may interact with strong CYP3A4 inhibitors or inducers, such as certain antibiotics or antifungals, which can change how your body processes the medication. Grapefruit and grapefruit juice may also affect everolimus levels. Avoid alcohol and consult your healthcare provider before starting new medications or supplements while taking AFINITOR 5mg.

Frequently Asked Questions

Everolimus is used to treat advanced kidney cancer, pancreatic neuroendocrine tumors, and breast cancer in postmenopausal women. It is also used for tuberous sclerosis complex in adults and children.

Store AFINITOR 5mg tablets at room temperature in a dry place. Keep the bottle tightly closed and away from children and pets.

It is not recommended to consume grapefruit or grapefruit juice while taking AFINITOR 5mg, as it may affect how your body processes the medication.

If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take two doses at once to make up for a missed dose.

Common side effects may include fatigue, nausea, or changes in appetite. Always discuss any side effects with your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.